Avedro’s Eye Drug-Device Combo Haunted By Past Sponsor’s Decisions
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA advisory committees will weigh clinical trial design, low study enrollment and device changes in review of application for two orphan eye conditions that Avedro didn’t have control over.